Prime Medicine Balance Sheet Health
Financial Health criteria checks 6/6
Prime Medicine has a total shareholder equity of $133.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $193.9M and $60.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$121.67m |
| Equity | US$133.07m |
| Total liabilities | US$60.78m |
| Total assets | US$193.85m |
Recent financial health updates
Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans?
Aug 25
We're Not Very Worried About Prime Medicine's (NASDAQ:PRME) Cash Burn Rate
May 12Will Prime Medicine (NASDAQ:PRME) Spend Its Cash Wisely?
Jan 24Recent updates
Prime Medicine's Investment Potential: A Deep Dive Into Innovation And Gene Editing
Jan 28Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans?
Aug 25We're Not Very Worried About Prime Medicine's (NASDAQ:PRME) Cash Burn Rate
May 12Will Prime Medicine (NASDAQ:PRME) Spend Its Cash Wisely?
Jan 24Financial Position Analysis
Short Term Liabilities: PRME's short term assets ($143.0M) exceed its short term liabilities ($56.4M).
Long Term Liabilities: PRME's short term assets ($143.0M) exceed its long term liabilities ($4.4M).
Debt to Equity History and Analysis
Debt Level: PRME is debt free.
Reducing Debt: PRME had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PRME has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: PRME is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.